A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
Public ClinicalTrials.gov record NCT01143077. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, 6-week, Open-Label, Study Evaluating The Safety, Tolerability, and Efficacy of Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Lurasidone (lurasidone HCl) is a novel psychotropic agent that is being developed as a potential new antipsychotic treatment for patients with schizophrenia. Switching between antipsychotic medications is common in the treatment of schizophrenia. The current study is designed to evaluate the effectiveness, safety, and tolerability of switching clinically stable, but symptomatic outpatients with schizophrenia or schizoaffective disorder from their preswitch antipsychotic medication to lurasidone, over a period of 6 weeks.
Study identification
- NCT ID
- NCT01143077
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 244 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2010 (Type not available)
- Primary completion
- May 2011 (Actual)
- Completion
- May 2011 (Actual)
- Last update posted
- Apr 17, 2013
2010 – 2011
United States locations
- U.S. sites
- 27
- U.S. states
- 12
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| K and S Professional Research Services | Little Rock | Arkansas | 72201 | — |
| Synergy Clinical Research of Escondido | Escondido | California | 92025 | — |
| Collaborative Neuroscience Network, Inc. | Garden Grove | California | 92845 | — |
| Pacific Research Partners, LLC | Oakland | California | 94612 | — |
| California Clinical Trials | Paramount | California | 90723 | — |
| Pasadena Research Institute | Pasadena | California | 91107 | — |
| California Neuropsychopharmacology Clinical Research Institute (CNRI), LLC | Pico Rivera | California | 90660 | — |
| California Neuropsychopharmacology Clinical Research Institute (CNRI) | San Diego | California | 92102 | — |
| University of California San Diego Medical Center | San Diego | California | 92103-8218 | — |
| Collaborative Neuroscience Network, South Bay | Torrance | California | 90502 | — |
| Western Affiliated Research Institute | Denver | Colorado | 80204 | — |
| Comprehensive NeuroScience, Inc. | Atlanta | Georgia | 30328 | — |
| Medical College of Georgia | Augusta | Georgia | 30912 | — |
| University of Illinois at Chicago | Chicago | Illinois | 60612 | — |
| Lake Charles Clinical Trials, LLC | Lake Charles | Louisiana | 70601 | — |
| Saint Charles Psychiatric Associates/Midwest Research Group | Saint Charles | Missouri | 63301 | — |
| Neurobehavioral Research, Inc. | Cedarhurst | New York | 11516 | — |
| The Zucker Hillside Hospital | Glen Oaks | New York | 11004 | — |
| Duke University Dept. of Psychiatry | Durham | North Carolina | 27710 | — |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | — |
| CRI Worldwide - Kirkbride Center | Philadelphia | Pennsylvania | 19131 | — |
| FutureSearch Clinical Trials, LP | Austin | Texas | 78731 | — |
| FutureSearch Trials of Dallas | Dallas | Texas | 75231 | — |
| Pillar Clinical Research, LLC | Dallas | Texas | 75243 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390-8828 | — |
| Wharton Research Center | Houston | Texas | 77488 | — |
| University of Utah Hospitals and Clinics | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01143077, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 17, 2013 · Synced Nov 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01143077 live on ClinicalTrials.gov.